Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Reitar Logtech | RITR | Nov 29, 2024 | 4.15 | 0.00 |
Rekor Systems | REKR | Nov 29, 2024 | 0.97 | +1.10 |
Relay Therapeutics | RLAY | Nov 29, 2024 | 4.70 | -2.08 |
Reliance | RS | Nov 29, 2024 | 321.24 | -0.42 |
Reliance Global | RELI | Nov 29, 2024 | 1.51 | -1.31 |
Relmada Therapeutics | RLMD | Nov 29, 2024 | 3.02 | +4.14 |
RELX ADR | RELX | Nov 29, 2024 | 47.08 | +0.06 |
Remitly Global | RELY | Nov 29, 2024 | 20.56 | -1.30 |
Renaissance Ipo ETF | IPO | Nov 29, 2024 | 46.07 | -0.55 |
RenaissanceRe | RNR | Nov 29, 2024 | 286.15 | +0.25 |
RenaissanceRe G Pref | RNR-G | Nov 29, 2024 | 18.40 | +1.71 |
RenaissanceRe Holding F Pref | RNR-F | Nov 29, 2024 | 24.43 | -0.44 |
Renalytix ADR | RNLX | Nov 29, 2024 | 0.20 | 0.00 |
Renasant | RNST | Nov 29, 2024 | 37.62 | -0.69 |
ReNew Energy Global A Shares | RNW | Nov 29, 2024 | 6.03 | -0.99 |
Renn Fund | RCG | Nov 29, 2024 | 2.77 | +10.36 |
Renovaro Biosciences | RENB | Nov 29, 2024 | 0.76 | +23.94 |
RenovoRx | RNXT | Nov 29, 2024 | 1.27 | +0.79 |
Rent The Runway A | RENT | Nov 29, 2024 | 11.73 | +17.42 |
Rentokil Initial ADR | RTO | Nov 29, 2024 | 25.54 | -0.66 |
Repare Therapeutics | RPTX | Nov 29, 2024 | 3.28 | -1.20 |
Repay A | RPAY | Nov 29, 2024 | 8.08 | -1.58 |
Repligen | RGEN | Nov 29, 2024 | 150.54 | +0.37 |
Replimune Group | REPL | Nov 29, 2024 | 14.08 | +0.21 |
ReposiTrak | TRAK | Nov 29, 2024 | 22.98 | +0.57 |
Republic Bancorp A | RBCAA | Nov 29, 2024 | 76.28 | -1.40 |
Republic Services | RSG | Nov 29, 2024 | 218.30 | +0.01 |
Research Frontiers | REFR | Nov 29, 2024 | 1.95 | 0.00 |
Research Solutions | RSSS | Nov 29, 2024 | 3.47 | +1.46 |
Reservoir Media | RSVR | Nov 29, 2024 | 9.44 | +1.83 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.